Clinical Trials in Pittsburgh

Showing 5221-5240 of 21,047 trials

9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma

NCT05239182

This trial examines how Pancreatic Adenocarcinoma reacts to the addition of 9-ING-41 and retifanlimab to the standard of care chemotherapy treatment, to see if using this combination will help and is able to effect disease progression.

Pancreatic Adenocarcinoma

Anwaar Saeed7 participantsStarted Jan 2022

Fairway, Kansas, United States • Pittsburgh, Pennsylvania, United States

RECRUITINGPhase 3< 1 mile

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

NCT05261139

The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID-19). The study medicine will be given to patients under 18 years of age with COVID-19 that are not hospitalized but are at risk for severe disease.

COVID-19

Pfizer160 participantsStarted Mar 2022

Phoenix, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +70 more locations

9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

Find Trials by Condition in Pittsburgh

Valved Graft PMCF Study

Expanded Clinical Study of the Tendyne Mitral Valve System

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

A Study of RSLV-132 in Females With Sjögren's Disease

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

Long Term Follow Up for CTSN Mitral Valve Repair Studies

MicroRNAs as Biomarkers for Obstructive Sleep Apnea

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Researching the Effect of Aerobic Exercise on Cancer

Helping HAND: Healing Anorexia Nervosa Digitally

Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel

Study to Assess AFM24 in Advanced Solid Cancers

Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction